Tesamorelin, Ipamorelin 8mg (Blend) — Dual-Action Growth Hormone Secretagogue Research Blend

This specialized 8mg synergistic blend combines Tesamorelin and Ipamorelin, two of the most highly regarded growth hormone-releasing agents in peptide science. By pairing a potent Growth Hormone-Releasing Hormone (GHRH) analogue with a selective Growth Hormone Secretagogue Receptor (GHSR) agonist, this formulation allows researchers to explore the maximized pulsatile release of endogenous growth hormone via two distinct cellular pathways.

• Dual-Mechanism Release Synergy: Simultaneously targets pituitary GHRH receptors and ghrelin receptors to evaluate amplified, natural growth hormone secretions without significantly impacting cortisol, prolactin, or blood glucose baselines.

• Key Research Areas: Extensively utilized in cellular biology and metabolic research to investigate visceral adipose tissue reduction, lipid metabolism optimization, cellular repair mechanisms, and lean tissue preservation models.

• Purity Guaranteed: $\ge 99\%$ purity of each constituent peptide in the blend, verified by rigorous HPLC and Mass Spectrometry testing to ensure precise and repeatable experimental data.

• Optimal Stability: Supplied as a sterile, lyophilized powder format to maintain structural integrity and allow for precise reconstitution in in vitro and laboratory assays.

Note: This product is sold strictly as a high-purity research chemical. It is intended solely for laboratory, in vitro, or animal research applications and is not approved for human injection, therapeutic, or diagnostic use.